Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
Kleiman NS, Van Mieghem NM, Reardon MJ, Gada H, Mumtaz M, Olsen PS, Heiser J, Merhi W, Chetcuti S, Deeb GM, Chawla A, Kiaii B, Teefy P, Chu MWA, Yakubov SJ, Windecker S, Althouse AD, Baron SJ. Kleiman NS, et al. Among authors: gada h. JACC Cardiovasc Interv. 2024 Apr 22;17(8):979-988. doi: 10.1016/j.jcin.2024.02.014. JACC Cardiovasc Interv. 2024. PMID: 38658126 Clinical Trial.
5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
Gada H, Kirtane AJ, Newman W, Sanz M, Hermiller JB, Mahaffey KW, Cutlip DE, Sudhir K, Hou L, Koo K, Stone GW. Gada H, et al. JACC Cardiovasc Interv. 2013 Dec;6(12):1263-6. doi: 10.1016/j.jcin.2013.07.009. Epub 2013 Nov 13. JACC Cardiovasc Interv. 2013. PMID: 24239202 Free article. Clinical Trial.
Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement.
Khalique OK, Hahn RT, Gada H, Nazif TM, Vahl TP, George I, Kalesan B, Forster M, Williams MB, Leon MB, Einstein AJ, Pulerwitz TC, Pearson GD, Kodali SK. Khalique OK, et al. Among authors: gada h. JACC Cardiovasc Interv. 2014 Aug;7(8):885-94. doi: 10.1016/j.jcin.2014.03.007. JACC Cardiovasc Interv. 2014. PMID: 25147034 Free article.
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators. Reardon MJ, et al. Among authors: gada h. N Engl J Med. 2017 Apr 6;376(14):1321-1331. doi: 10.1056/NEJMoa1700456. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304219 Free article. Clinical Trial.
Who's afraid of the big bad wolf?
Mumtaz M, Gada H, Mack MJ, Reardon MJ. Mumtaz M, et al. Among authors: gada h. J Thorac Cardiovasc Surg. 2017 Jun;153(6):1287-1289. doi: 10.1016/j.jtcvs.2017.02.035. Epub 2017 Mar 7. J Thorac Cardiovasc Surg. 2017. PMID: 28343688 Free article. No abstract available.
In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO Registry.
Salisbury AC, Karmpaliotis D, Grantham JA, Sapontis J, Meng Q, Magnuson EA, Gada H, Lombardi W, Moses J, Li H, Arnold SV, Baron SJ, Spertus JA, Cohen DJ. Salisbury AC, et al. Among authors: gada h. JACC Cardiovasc Interv. 2019 Feb 25;12(4):323-331. doi: 10.1016/j.jcin.2018.10.025. Epub 2019 Jan 30. JACC Cardiovasc Interv. 2019. PMID: 30711549 Free article.
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ; Evolut Low Risk Trial Investigators. Popma JJ, et al. Among authors: gada h. N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16. N Engl J Med. 2019. PMID: 30883053 Clinical Trial.
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial.
Van Mieghem NM, Popma JJ, Deeb GM, Yakubov SJ, Serruys PW, Windecker S, Søndergaard L, Mumtaz M, Gada H, Chetcuti S, Kleiman NS, Kodali S, George I, Teefy P, Kiaii B, Oh JK, Kappetein AP, Chang Y, Mugglin AS, Reardon MJ; SURTAVI Trial Investigators. Van Mieghem NM, et al. Among authors: gada h. JACC Cardiovasc Interv. 2020 Feb 10;13(3):323-331. doi: 10.1016/j.jcin.2019.10.043. JACC Cardiovasc Interv. 2020. PMID: 32029248 Free article. Clinical Trial.
Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study.
Blanke P, Leipsic JA, Popma JJ, Yakubov SJ, Deeb GM, Gada H, Mumtaz M, Ramlawi B, Kleiman NS, Sorajja P, Askew J, Meduri CU, Kauten J, Melnitchouk S, Inglessis I, Huang J, Boulware M, Reardon MJ; Evolut Low Risk LTI Substudy Investigators. Blanke P, et al. Among authors: gada h. J Am Coll Cardiol. 2020 May 19;75(19):2430-2442. doi: 10.1016/j.jacc.2020.03.022. Epub 2020 Mar 28. J Am Coll Cardiol. 2020. PMID: 32234463 Free article. Clinical Trial.
71 results